AmeriCann Provides Outlook on Tuesday's Senate Hearing to Improve Financial Access for Cannabis Companies

AmeriCann, Inc.

Companies Mentioned:

Primary Exchange: OTCQB
Under the Symbol: ACAN

AmeriCann Provides Outlook on Tuesday's Senate Hearing to Improve Financial Access for Cannabis Companies

Monday, July 22, 2019 8:45 AM

Adoption of the SAFE Banking Act Would Normalize Financial Operations for Cannabis Businesses

DENVER, CO / ACCESSWIRE / July 22, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and manufacturing facilities, commented on the upcoming hearing on the SAFE Banking Act and the positive outlook for federal cannabis legislation.

Sponsored by a bi-partisan group of 31 Senators, the SAFE Banking Act would give cannabis businesses, operating in states where cannabis is legal, access to banking and financial services. It would also protect banks that offer these services to regulated cannabis businesses. The hearing is scheduled for July 23 with Democratic Senator Jeff Merkley (D-OR), Senator Cory Gardner (R-CO) and representatives from the financial and cannabis industries scheduled to testify.

“After decades of advocacy and cannabis policy development, we are experiencing overwhelming public support for medical and adult-access cannabis in the U.S.,” says AmeriCann CEO Tim Keogh. “Making it possible for cannabis businesses to access capital and other banking services like all other legal businesses would clear the way for greater innovation and growth in the industry.”

According to a Gallup poll conducted in October 2018, 66 percent of Americans now support the legalization of recreational cannabis. Medical marijuana is legal in 33 states and recreationally legal in 11 of those states plus Washington D.C.

“Millions of Americans still do not have access to medical cannabis,” stated Ben Barton, founder of AmeriCann. “One of the major benefits to the end of cannabis prohibition is that it should accelerate the number of states that embrace and regulate medical cannabis and expand the availability of safe, effective medicine for patients. Eliminating banking and financial barriers will serve as a major catalyst for this industry.”

AmeriCann is nearing completion on the first of three buildings in its Massachusetts Marijuana Center (MCC) being developed on a 52-acre parcel located in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure for the existing medical cannabis and the newly emerging adult-use cannabis marketplace.

AmeriCann’s Cannopy System, which will be used at the MCC, enables cannabis to be produced with a greatly reduced carbon footprint, making the final product cost less with higher margins. AmeriCann uses hybrid-greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25 percent fewer lights, and utility bills are up to 75 percent less than in typical warehouse cultivation facilities. Massachusetts has some of the highest energy costs in the nation, providing an even greater advantage to the MCC.

AmeriCann plans to replicate the brands, technology and innovations developed at its MCC project to new markets as a licensed multi-state operator (MSO).

As the first approved adult-use cannabis market on the Eastern U.S., Massachusetts has the potential to become the epicenter for cannabis innovation and research. According to the Cannabis Control Commission, Massachusetts recreational dispensaries have sold more than $170 million worth of cannabis products since recreational sales began in November 2018. Annual recreational retail sales are expected to total $1.3-1.6 billion in a few years, according to Marijuana Business Daily estimates.

About AmeriCann

AmeriCann (OTCQB: ACAN) is a cannabis company that is developing cultivation, processing and product manufacturing facilities.

AmeriCann uses greenhouse technology for cannabis cultivation and is designing GMP Certified cannabis extraction and product manufacturing infrastructure. Through a wholly-owned subsidiary, AmeriCann Brands, Inc., the Company intends to secure licenses to cultivate cannabis and produce cannabis infused products including beverages, edibles, topicals, vape cartridges and concentrates. AmeriCann Brands, Inc. plans to operate a Marijuana Product Manufacturing business at the Massachusetts Cannabis Center with over 40,000 square feet of state-of-the art extraction and product manufacturing infrastructure.

More information about the Company is available at: www.americann.co, or follow AmeriCann on social media:

About Massachusetts Cannabis Center

Massachusetts Cannabis Center (MCC), is a one million square foot sustainable greenhouse, processing and manufacturing facility in Freetown, Mass which is being developed by AmeriCann. The first phase of the facility is scheduled to open and be ready for cannabis cultivation, processing, and infused product production in the summer of 2019. Once fully developed, the MCC design calls for a research facility, a training center, corporate offices, a quality-assurance laboratory, and a facility for manufacturing cannabis-infused food, nutraceuticals and consumer packaged cannabis goods.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company's forward-looking statements, please see the Company’s Registration Statement on Form S-1, which the Company recently filed with the SEC and which may be viewed at www.sec.gov.

Contact Information:

Corporate and Investors
AmeriCann, Inc.
1550 Wewatta Street
2nd Floor
Denver, CO 80202
(303) 862-9000
[email protected]
www.americann.co
@ACANinfo on Twitter
@AmeriCann on Facebook
@AmeriCannInc on Instagram
AmeriCann, Inc on LinkedIn

Media:
Teak Media + Communication
Kelley Buck
[email protected]
617-269-7171

SOURCE: AmeriCann, Inc.


SHARE ARTICLE